Journal
ADVANCED DRUG DELIVERY REVIEWS
Volume 97, Issue -, Pages 56-68Publisher
ELSEVIER
DOI: 10.1016/j.addr.2015.12.016
Keywords
Extracellular matrix; Matricellular; Cell-matrix interactions; Angiogenesis; Fibrosis
Categories
Funding
- National Institutes of Health [GM072194, HL 107205, T32HL007950-12]
Ask authors/readers for more resources
Extracellular matrix is composed of a complex array of molecules that together provide structural and functional support to cells. These properties are mainly mediated by the activity of collagenous and elastic fibers, proteoglycans, and proteins such as fibronectin and laminin. ECM composition is tissue-specific and could include matricellular proteins whose primary role is to modulate cell-matrix interactions. In adults, matricellular proteins are primarily expressed during injury, inflammation and disease. Particularly, they are closely associated with the progression and prognosis of cardiovascular and fibrotic diseases, and cancer. This review aims to provide an overview of the potential use of matricellular proteins in drug delivery including the generation of therapeutic agents based on the properties and structures of these proteins as well as their utility as biomarkers for specific diseases. (C) 2016 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available